Exhibit 99.3

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Shares, without par value, of Edesa Biotech, Inc., a British Columbia corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

 

Velan Capital Master Fund LP
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner
Date: 02/18/2025

 

Velan Horizon Fund LP
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member of Velan Horizon GP LLC, its General Partner
Date: 02/18/2025

 

Velan Capital Opportunity Fund II LLC
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member of Velan Capital Holdings LLC, its Managing Member

 

Velan Horizon GP LLC
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member
Date: 02/18/2025

 

Velan Capital Holdings LLC
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member
Date: 02/18/2025

 

Velan Capital Investment Management LP
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner
Date: 02/18/2025

 

Velan Capital Management LLC
 
By:

/s/ Adam Morgan

  
  Adam Morgan, Managing Member
Date: 02/18/2025

 

 

 

Morgan Adam
 
By:

/s/ Adam Morgan

  
  Adam Morgan
Date: 02/18/2025

 

VENKATARAMAN BALAJI
 
By:

/s/ Balaji Venkataraman

  
  Balaji Venkataraman
Date: 02/18/2025

 

Edesa Biotech (NASDAQ:EDSA)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Edesa Biotech.
Edesa Biotech (NASDAQ:EDSA)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Edesa Biotech.